DrugCite
Search

MEPTIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Meptin Adverse Events Reported to the FDA Over Time

How are Meptin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Meptin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Meptin is flagged as the suspect drug causing the adverse event.

Most Common Meptin Adverse Events Reported to the FDA

What are the most common Meptin adverse events reported to the FDA?

Interstitial Lung Disease
5 (3.52%)
Tachycardia
5 (3.52%)
Hepatic Function Abnormal
4 (2.82%)
Hypokalaemia
4 (2.82%)
Loss Of Consciousness
4 (2.82%)
Tremor
4 (2.82%)
Chills
3 (2.11%)
Convulsion
3 (2.11%)
Hypoaesthesia
3 (2.11%)
Mumps
3 (2.11%)
Nasopharyngitis
3 (2.11%)
Show More Show More
Palpitations
3 (2.11%)
Tooth Discolouration
3 (2.11%)
Tooth Hypoplasia
3 (2.11%)
Abnormal Behaviour
2 (1.41%)
Altered State Of Consciousness
2 (1.41%)
Amnesia
2 (1.41%)
Coma
2 (1.41%)
Dyspnoea
2 (1.41%)
Eosinophilic Pneumonia
2 (1.41%)
Fracture
2 (1.41%)
Hallucination
2 (1.41%)
Hallucination, Visual
2 (1.41%)
Headache
2 (1.41%)
Local Swelling
2 (1.41%)
Nausea
2 (1.41%)
Neutropenia
2 (1.41%)
Rash
2 (1.41%)
Rhabdomyolysis
2 (1.41%)
Status Asthmaticus
2 (1.41%)
Suicide Attempt
2 (1.41%)
Abdominal Pain Upper
1 (.7%)
Aggression
1 (.7%)
Alanine Aminotransferase Increased
1 (.7%)
Anaemia
1 (.7%)
Anaphylactic Shock
1 (.7%)
Arrhythmia
1 (.7%)
Aspartate Aminotransferase Increase...
1 (.7%)
Asthma
1 (.7%)
Atrial Fibrillation
1 (.7%)
Atrial Flutter
1 (.7%)
Blood Potassium Decreased
1 (.7%)
Blood Potassium Increased
1 (.7%)
Bronchitis
1 (.7%)
Cardiac Disorder
1 (.7%)
Cell Marker Increased
1 (.7%)
Chest Pain
1 (.7%)
Condition Aggravated
1 (.7%)
Crying
1 (.7%)
Dehydration
1 (.7%)
Delirium
1 (.7%)
Dizziness
1 (.7%)
Drug Hypersensitivity
1 (.7%)
Drug Toxicity
1 (.7%)
Dyspnoea Exertional
1 (.7%)
Eosinophil Count Increased
1 (.7%)
Eosinophilia
1 (.7%)
Faeces Discoloured
1 (.7%)
Hepatosplenic T-cell Lymphoma
1 (.7%)
Injury
1 (.7%)
Insomnia
1 (.7%)
Intentional Overdose
1 (.7%)
Liver Disorder
1 (.7%)
Lung Consolidation
1 (.7%)
Lymphadenopathy
1 (.7%)
Lymphocyte Stimulation Test Positiv...
1 (.7%)
Malaise
1 (.7%)
Mental Disorder
1 (.7%)
Muscle Spasms
1 (.7%)
Oedema Peripheral
1 (.7%)
Oesophageal Candidiasis
1 (.7%)
Overdose
1 (.7%)
Pancytopenia
1 (.7%)
Pleural Effusion
1 (.7%)
Pneumonia Klebsiella
1 (.7%)
Pre-existing Disease
1 (.7%)
Pseudomonas Infection
1 (.7%)
Renal Failure Acute
1 (.7%)
Respiratory Distress
1 (.7%)
Restlessness
1 (.7%)
Screaming
1 (.7%)
Spinal Disorder
1 (.7%)
Splenomegaly
1 (.7%)
Staphylococcal Infection
1 (.7%)
Transplant Rejection
1 (.7%)
Tuberculin Test Positive
1 (.7%)
Upper Respiratory Tract Infection
1 (.7%)
Vasculitis
1 (.7%)
Vision Blurred
1 (.7%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Meptin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Meptin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Meptin

What are the most common Meptin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Meptin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Meptin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Meptin According to Those Reporting Adverse Events

Why are people taking Meptin, according to those reporting adverse events to the FDA?

Asthma
144
Product Used For Unknown Indication
70
Drug Use For Unknown Indication
29
Chronic Obstructive Pulmonary Disea...
19
Bronchitis
10
Pneumonia
10
Show More Show More
Cough
9
Emphysema
9
Bronchitis Chronic
8
Prophylaxis
5
Streptococcal Infection
4
Interstitial Lung Disease
4
Bronchiectasis
4
Nasopharyngitis
4
Asthma Prophylaxis
3
Upper Respiratory Tract Inflammatio...
2
Influenza
2
Productive Cough
1
Pneumonia Bacterial
1
Dyspnoea
1
Respiratory Therapy
1
Bronchitis Acute
1
Respiratory Disorder
1
Intentional Overdose
1
Respiratory Tract Infection
1

Meptin Case Reports

What Meptin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Meptin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Meptin.